Literature DB >> 28647524

Preparation and evaluation of BSA-based hydrosol nanoparticles cross-linked with genipin for oral administration of poorly water-soluble curcumin.

Narges Shahgholian1, Ghadir Rajabzadeh2, Bizhan Malaekeh-Nikouei3.   

Abstract

One of the most interesting functions of albumin is the ability to interact with bioactive compounds. This study describes preparation of protein-based nanoparticles (NPs) for the preparation of solid dispersion of curcumin (CN). Fabrication of hydrosol system of dispersed CN in bovine serum albumin (BSA) was approached, followed by cross-linking with glutaraldehyde (Gta). Response surface methodology (RSM) was used to investigate the influence of input factors (pH, CN content and organic phase ratio (r)), on the particle size and CN entrapment efficiency (EE). Particle size, EE and CN loading efficiency (LE) at optimum condition (pH 7, r 10% and 3.4mg of CN content), were found to be in the range of 153-184.4nm, 72.54%, and 14.508μg/mg, respectively. In the optimum formulation, genipin (Gnp) was used at three different levels (0.1-0.2 and 0.3% w/w of BSA), as a safe, natural cross-linker instead of toxic Gta, to address the limitation of oral delivery purpose. AFM and SEM analysis revealed the spherical and smooth surface of Nps. Ninhydrin (NHD) assay and FT-IR analysis confirmed the cross-linking between BSA and Gnp. In vitro release studies ensure the efficiency of the formulation for sustained release of soluble CN.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bovine serum albumin; Curcumin; Genipin; Hydrosol nanoparticles; Natural cross-linker; RSM

Mesh:

Substances:

Year:  2017        PMID: 28647524     DOI: 10.1016/j.ijbiomac.2017.06.083

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

1.  Biotransformation of Geniposide into Genipin by Immobilized Trichoderma reesei and Conformational Study of Genipin.

Authors:  Yishun Yang; Yue Ding; Tong Zhang
Journal:  Biomed Res Int       Date:  2018-04-12       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.